Management of osteoporosis in a pre-menopausal woman

Best Practice and Research: Clinical Rheumatology

Volumn 24, Issue 3, 2010, Pages 313-327

  Bhalla, Ashok K ^a  

^a ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

Author keywords

anabolic therapy; anorexia nervosa; anti resorptive therapy; diabetes mellitus; drug related osteoporosis; endocrine disorders; gastrointestinal disorders; glucocorticoid induced bone loss; hyperthyroidism; liver disease and pancreatic insufficiency; pregnancy associated osteoporosis; primary hyperparathyroidism; transplantation osteoporosis; Z score

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALENDRONIC ACID; ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCINEURIN INHIBITOR; CALCITONIN; CALCITRIOL; CALCIUM; CYCLOSPORIN A; ESTROGEN; GLUCOCORTICOID; GONADORELIN AGONIST; HEPARIN; IBANDRONIC ACID; IMMUNOSUPPRESSIVE AGENT; LITHIUM; METHOTREXATE; ORAL CONTRACEPTIVE AGENT; PAMIDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PREDNISOLONE; PROGESTERONE; RECOMBINANT SOMATOMEDIN C; RISEDRONIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TACROLIMUS; THYROXINE; VITAMIN D; ZOLEDRONIC ACID; BONE DENSITY CONSERVATION AGENT;

ADRENAL INSUFFICIENCY; ALCOHOL CONSUMPTION; AMENORRHEA; AMYLOIDOSIS; ANKYLOSING SPONDYLITIS; ANOREXIA NERVOSA; ARTHRITIS; BLOOD CELL COUNT; BONE DENSITY; BONE MASS; BONE NECROSIS; BULIMIA; CALCIUM DEFICIENCY; CELIAC DISEASE; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; CORTICOSTEROID INDUCED OSTEOPOROSIS; CORTICOSTEROID THERAPY; CROHN DISEASE; CUSHING SYNDROME; DRUG ACCUMULATION; DRUG DOSE REDUCTION; DRUG INTERMITTENT THERAPY; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; EATING DISORDER; ECCHYMOSIS; EHLERS DANLOS SYNDROME; ENDOCRINE DISEASE; ENDOMETRIOSIS; ENTERITIS; FEMALE ATHLETE TRIAD; FLUID RETENTION; FOLLOW UP; FRACTURE; FRAGILITY FRACTURE; GLUTEN FREE DIET; HEART TRANSPLANTATION; HEMOCHROMATOSIS; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERPARATHYROIDISM; HYPERTENSION; HYPERTHYROIDISM; HYPOGONADISM; HYPOKALEMIA; IDIOPATHIC OSTEOPOROSIS; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LABORATORY TEST; LACTATION; LEUKEMIA; LIFESTYLE; LIVER DISEASE; LIVER FUNCTION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; LYMPHOMA; MALABSORPTION; MARFAN SYNDROME; MULTIPLE MYELOMA; MYOPATHY; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL DEFICIENCY; OBESITY; OSTEOGENESIS IMPERFECTA; OSTEOPENIA; OSTEOPOROSIS; PANCREAS INSUFFICIENCY; PATIENT ASSESSMENT; PLACENTA; PLASMA VISCOSITY; PREGNANCY; PREMENOPAUSE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SICKLE CELL ANEMIA; SIDE EFFECT; SKELETON; SKIN FRAGILITY; SMOKING; SPINE RADIOGRAPHY; STRESS FRACTURE; SYSTEMIC LUPUS ERYTHEMATOSUS; THALASSEMIA; THROMBOEMBOLISM; THYROID FUNCTION; ULCERATIVE COLITIS; VERTEBRA FRACTURE; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WEIGHT GAIN; WITHDRAWAL SYNDROME; WOUND HEALING IMPAIRMENT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; OSTEOLYSIS; PATHOLOGIC FRACTURE; PHYSIOLOGY;

ANOREXIA NERVOSA; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; FEMALE; FRACTURES, SPONTANEOUS; GLUCOCORTICOIDS; HUMANS; OSTEOPOROSIS; PREMENOPAUSE;

EID: 77956627547     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2010.01.006     Document Type: Review

References (63)

1. V. Matkovic, T. Jelic, and G.M. Wardlaw Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis: inference from a cross-sectional model J Clin Invest 93 1994 799 808
2. C. Cooper, M. Cawley, and A. Bhalla Childhood growth, physical activity and peak bone mass in women J Bone Miner Res 10 1995 940 947
3. L.A. Rubin, G.A. Hawker, and V.D. Peltekova Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort J Bone Miner Res 14 1999 633 643
4. M. Gourlay, and S.A. Brown Clinical considerations in premenopausal osteoporosis Arch Intern Med 164 2004 603 614
5. Available at: www.iscd.org/visitors/positions/officialpositionstext.cfm
6. P.W. Thompson, J. Taylor, and A. Dawson The annual incidence and seasonal variations of fractures of the distal radius in men and women over 25 years in Dorset, UK Injury 35 2004 462 466
7. F. Wu, B. Mason, and A. Horac Fractures between the ages of 20 and 50 years increase women's risk of subsequent fractures Arch Intern Med 162 2002 33 36
8. C.A. Wigderowitz, T. Cunningham, and D.I. Rowley Peripheral bone mineral density in patients with distal radial fractures J Bone Joint Surg Br. 85 2003 423 425
9. L.K. Hung, H.T. Wu, and P.C. Leung Low BMD is a risk factor for low-energy Colles' fractures in women before and after menopause Clin Orthop 435 2005 219 225
10. S. Kumagi, S. Kawano, and T. Atsumi Vertebral fractures and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseases J Rheumatol 2005 843 869
11. P. Peris, N. Guanabens, and M.J. Martinez de osaba Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women Semin Arthritis Rheum 32 2002 64 70
12. S. Grinspoon, E. Thomas, and S. Pitts Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa Ann Intern Med 133 2000 790 794
13. B.M.K. Biller, V. Saxe, and D.B. Herzog Mechanism of osteoporosis in adults and adolescent women with anorexia nervosa J Clin Endocrinol Metab 68 1989 548 554
14. S. Grinspoon, K. Miller, and C. Coyle Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea J Clin Endocrinol Metab 84 1999 2049 2055
15. J. Dominguez, L. Goodman, and S.S. Gupta Treatment of anorexia nervosa is associated with increases in bone mineral density, and recovery is a biphasic process involving both nutrition and return of menses Am J Clin Nutr 86 2007 92 99
16. K.K. Miller, K.A. Grieco, and J. Mulder Effects of risedronate on bone density in anorexia nervosa J Clin Endocrinol Metab 89 2004 3903 3906
17. N.H. Gold, E.A. Iglesias, and M.S. Jacobson Alendronate for the treatment of osteopenia in anorexia nervosa: a randomised, double-blind, placebo-controlled trial J Clin Endocrinol Metab 90 2005 3179 3185
18. R.S. Weinstein Glucocorticoid-induced osteoporosis Rev Endocr Metab Disord 2 2001 65 73
19. E. Canalis, G. Mazziotti, and A. Giustina Glucocorticoid-induced osteoporosis: pathophysiology and therapy Osteoporos Int 18 2007 1319 1328
20. G. Mazziotti, A. Angeli, and J.P. Bilezikian Glucocorticoid-induced osteoporosis: an update Trends Endocrinol Metab 7 2006 144 149
21. R.S. Weinstein, R.W. Nicholas, and S.C. Manolagas Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip J Clin Endocrinol Metab 85 2000 2907 2912
22. D. Jia, C.A. O'Brien, and S.A. Stewart Glucocorticoids act directly on osteoclasts to increase their lifespan and reduce bone density Endocrinology 147 2006 5592 5599
23. E. Pas-Pacheco, G.E.H. Fuleihan, and M.S. LeBoff Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects J Bone Miner Res 10 1995 1713 1718
24. L. Fitzpatrick Secondary causes of osteoporosis Mayo Clin Proc 77 2002 453 468
25. T.P. Van Staa, R.F. Laan, and I.P. Barton Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy Arthritis Rheum 48 2003 3224 3229
26. T.P. Van Staa, H.G. Leufkens, and L. Abenhaim Use of oral corticosteroids and risk of fracture J Bone Miner Res 15 2000 993 1000 (Pubitemid 30350061)
27. Bone and Tooth Society, National Osteoporosis Society, and Royal College of Physicians Glucocorticoid-induced osteoporosis: guidelines for prevention and treatment 2002 RCP London
28. American College of Rheumatology Ad Hoc Committee on Glucocorticoid- induced osteoporosis Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis Arthritis Rheum 44 2001 1496 1503
29. J.D. Adachi, K.G. Saag, and P.D. Delman Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial Arthritis Rheum 44 2001 202 211
30. D.M. Reid, R.A. Hughes, and R.F.J.M. Laan Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomised trial J Bone Mineral Res 15 2000 1006 1013
31. R.N. de Nijs, J.W. Jacobs, and W.F. Lems Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis N Eng J Med 355 2006 675 684
32. K.G. Saag, E. Shone, and S. Boonen Teriparatide or alendronate in glucocorticoid-induced osteoporosis N Eng J Med 357 2007 2028 2039
33. J.P. Bilezikian, and S.J. Silverberg Clinical spectrum of primary hyperparathyroidism Rev Endocr Metabo Disord 1 2000 237 245
34. st Century J Bone Miner Res 17 2002 N2 N11
35. K.K. Nicodemus, A.R. Folsom, and Iowa Women's Health Study Type 1 and Type 2 diabetes and incident hip fractures in postmenopausal women Diabetes Care 24 2001 1192 1197
36. L.C. Hofbauer, C.C. Brueck, and S.K. Singh Osteoporosis in patients with diabetes mellitus J Bone Miner Res 22 2007 1317 1328
37. X.A. McFarlane, A.K. Bhalla, and D.E. Reeves Osteoporosis in treated adult coeliac disease Gut 36 1995 710 714
38. X.A. McFarlane, A.K. Bhalla, and D.A.F. Robertson Effect of gluten-free diet on osteopenia in adults with newly diagnosed coeliac disease Gut 39 1996 180 184
39. M. Pazianas, G.P. Butcher, and J.M. Subhani Calcium absorption and bone mineral density in coeliacs after long term treatment with gluten-free diet and adequate calcium intake Osteoporos Int 16 2005 56 63
40. C. Schulte, A.V. Dignass, and K. Mann Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease Inflam Bowel Dis 4 1998 268 275
41. J. Compston Osteoporosis in inflammatory bowel disease Gut 52 2003 63 64
42. R.A. van Hogezand, D. Banffer, and A.H. Zwinderman Ileum resection is the most predictive factor for osteoporosis in Crohn's disease Osteoporos Int 17 2006 535 542
43. L.C.M. Serge, S.C. Cremers, and R. van Hogezand Absorption of oral bisphosphonate alendronate in osteoporotic patients with Crohn's disease Osteoporos Int 16 2005 1727 1736
44. R. Lindsay Bone loss after cardiac transplantation N Eng J Med 350 2004 751 754
45. A. Cohen, P. Sambrook, and E. Shane Management of bone loss after organ transplantation J Bone Miner Res 19 2004 1919 1932
46. A. Cohen, and E. Shane Osteoporosis after solid organ and bone marrow transplantation Osteoporos Int 14 2003 617 630
47. E. Shane, V. Addesso, and P.B. Namerow Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation N Eng J Med 350 2004 767 776 (Pubitemid 38209646)
48. N.J. Minaur, C. Jefferies, and A.K. Bhalla Methotrexate in the treatment of rheumatoid arthritis. I. In vitro effects on cells of the osteoblast lineage Rheumatology 41 2002 735 740
49. N.J. Minaur, D. Kounali, and S. Vedi Methotrexate in the treatment of rheumatoid arthritis. II. In vivo effects on bone mineral density Rheumatology 41 2002 741 749
50. S.J. Petty, T.J. O'Brien, and J.D. Wark Anti-epileptic medication and bone health Osteoporos Int 18 2007 129 142
51. J.S. Finkelstein, A. Klibanski, and A.L. Arnold Prevention of estrogen deficiency-related bone loss with human parathyroid hormone - (1-34). A randomized controlled trial JAMA 280 1998 1067 1073
52. A.J. Friedman, M. Daly, and M. Juneau-Norcross A prospective, randomized trial of gonadotrophin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri J Clin Endocrinol Metab 76 1993 1439 1445
53. F. Dunne, B. Walters, and T. Marshall Pregnancy associated osteoporosis Clin Endocrin 39 1993 487 490
54. W. Khovidhunkit, and S. Epstein Osteoporosis in pregnancy Osteoporos Int 6 1996 345 354
55. S.M. O'Sullivan, A.B. Grey, and R. Singh Bisphosphonate in pregnancy and lactation-associated osteoporosis Osteoporos Int 17 2006 1008 1012
56. S. Khosla, E.G. Lufkin, and S.F. Hodgson Epidemiology and clinical features of osteoporosis in young individuals Bone 15 1994 551 555
57. M.R. Rubin, D.H. Schussheim, and C.A.M. Kulak Idiopathic osteoporosis in premenopausal women Osteoporos Int 16 2005 526 533
58. M.C. Lodder, Z. de Jong, and P.J. Kostense Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density Ann Rheum Dis 63 2004 1576 1580
59. D.J. Speden, A.I. Calin, and F.J. Ring Bone mineral density, calcaneal ultrasound, and bone turnover markers in women with ankylosing spondylitis J Rheum 29 2002 516 521
60. R. Will, R. Palmer, and A.K. Bhalla Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 2 1989 1483 1485
61. C. Tudor-Locke, and R.S. McColl Factors related to variation in premenopausal bone mineral status: a health promotion approach Osteoporos Int 11 2000 1 24
62. S. Grinspoon, L. Thomas, and K. Miller Effects of recombinant Human IGF-1 and oral contraceptive administration on bone density in anorexia nervosa J Clin Endocrinol Metab 87 2002 2883 2891
63. J. Lappe, D. Cullen, and G. Haynatzki Calcium and vitamin D supplementation decreases incidence of stress fractures in female navy recruits J Bone Mineral Res 23 2008 741 749